miscsubjectsAI governance
Evidence review

Tesamorelin for Neuropathy: Evidence-Graded Review

· · 2 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `tesamorelin-neuropathy`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/tesamorelin-neuropathy

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-neuropathy/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tesamorelin-neuropathy/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tesamorelin-neuropathy/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tesamorelin-neuropathy/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why Tesamorelin might help you

  1. Therefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • Tesamorelin → GH axis / visceral fat

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 4
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 4

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.5 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury (source s1)

Active Phase 2 trial protocol details; no results posted.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury (source s2)

Trial background cites preclinical GH nerve data.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Effects of tesamorelin... in HIV-infected patients with abdominal fat accumulation (source s3)

Pooled Phase 3 data on VAT reduction and IGF-1 increase.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Tesamorelin Side Effects (source s4)

Lists neuropathy-related adverse events from approved use.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Safety and limits

  1. Paresthesia and peripheral neuropathy are listed among nervous system adverse events in tesamorelin prescribing information.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Neuropathy (general) · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedTesamorelin · 5 humanTesamorelin for Statin-Associated Cognitive Effects: Human Trial Evide… · 5 humanTesamorelin for Carpal Tunnel Syndrome: Evidence Review · 4 humanTesamorelin for Chemotherapy: Body Composition Evidence and Symptom Su… · 4 human
Evidence · 4 sources · swipe →chain 2f341cfc8d9e · verify chain · provenance
1 / 4
Evidence ledger 4 · tier-ranked · API
human
Paresthesia and peripheral neuropathy are listed among nervous system adverse events in tesamorelin prescribing information.
sources: s4
preclinical
Animal studies show growth hormone improves nerve regeneration and functional recovery after injury.
sources: s2
humanlow confidence
An ongoing Phase 2 RCT (NCT03150511) is testing tesamorelin for functional recovery after peripheral nerve injury with no published results yet.
sources: s1
humanlow confidence
Tesamorelin reduces visceral fat and increases IGF-1 in multiple human RCTs for HIV lipodystrophy.
sources: s3
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:18
Tesamorelin for Neuropathy: Evidence-Graded Review · 4 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Tesamorelin for Neuropathy
Slug: tesamorelin-neuropathy
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"tesamorelin","name":"Tesamorelin"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_w
it output
{
  "slug": "tesamorelin-neuropathy",
  "title": "Tesamorelin for Neuropathy: Evidence-Graded Review",
  "body": "## What's breaking down\n\nNeuropathy involves degeneration of peripheral nerves. Axons may be damaged or severed after injury or disease. Myelin sheaths can degrade. Schwann cells struggle to support regrowth. Blood flow to nerves may drop. Inflammation can persist. Over time, motor and sensory function decline because repair pathways lag behind ongoing breakdown.\n\n## Why Tesamorelin might help you\n\nTesamorelin stimulates the growth hormone axis. It raises GH and IGF-1 levels. If your neuropathy involves impaired axonal regeneration or muscle atrophy after nerve injury, this pathway is discussed for potential tissue repair support.\n\n1. Therefore for you: If axonal regrowth is a limiting factor, Tesamorelin is studied because GH/IGF-1 signaling has been linked in animal models to faster nerve fiber extension.\n2. Therefore for you: If muscle wasting follows denervation, the same axis may help preserve or rebuild muscle tissue indirectly.\n3. Therefore for you: If visceral fat or metabolic stress adds to nerve load, Tesamorelin's documented effect on reducing abdominal fat could ease secondary strain, though this remains separate from direct nerve effects.\n4. Therefore for you: Tesamorelin targets repair signaling rather than symptom masking.\n\n## How these f
0313958d0df265be
Machine verification: /api/articles/tesamorelin-neuropathy/contributions

Related articles

Neuropathy (general) · condition map

Open evidence map →
TesamorelintesamorelinTesamorelin for Benzodiazepine Withdrawal: Evidence Reviewtesamorelin-benzo-withdrawalTesamorelin for Benzodiazepines: Evidence Reviewtesamorelin-benzodiazepinesTesamorelin for Statin-Associated Cognitive Effects: Human Trial Evide…tesamorelin-brain-fogTesamorelin for Carpal Tunnel Syndrome: Evidence Reviewtesamorelin-carpal-tunnelTesamorelin for Chemotherapy: Body Composition Evidence and Symptom Su…tesamorelin-chemo
Ask this article · 6 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Paresthesia and peripheral neuropathy are listed among nervous system adverse events in tesamorelin prescribing information."?
ask tesamorelin-neuropathy claim c4 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Animal studies show growth hormone improves nerve regeneration and functional recovery after injury."?
ask tesamorelin-neuropathy claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "An ongoing Phase 2 RCT (NCT03150511) is testing tesamorelin for functional recovery after peripheral nerve injury with no published results …"?
ask tesamorelin-neuropathy claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "Tesamorelin reduces visceral fat and increases IGF-1 in multiple human RCTs for HIV lipodystrophy."?
ask tesamorelin-neuropathy claim c3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about Tesamorelin for Neuropathy: Evidence-Graded Review — and what would you need me to tell you first?
ask tesamorelin-neuropathy condition gaps · paste includes §SELF
What good and bad outcomes are documented for Tesamorelin for Neuropathy: Evidence-Graded Review (studies vs anecdotes)?
ask tesamorelin-neuropathy good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…